Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

152.35 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,321
Open 152.35
Bid (Size) 162.01 (200)
Ask (Size) 164.40 (100)
Prev. Close 152.35
Today's Range 152.35 - 152.35
52wk Range 40.35 - 174.08
Shares Outstanding 101,298,669
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Guardant Health (NASDAQ:GH) Shares Surge After Q2 Revenue Beat and Raised 2026 Outlook ↗
Via Chartmill
News headline image
Guardant Health (NASDAQ:GH) Delivers Strong Q2 CY2026 Numbers, Stock Soars
Diagnostics company Guardant Health (NASDAQ:GH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 44.3% year on year to $3... 
Via StockStory

Performance

YTD
+49.7%
+49.7%
1 Month
+1.5%
+1.5%
3 Month
+75.0%
+75.0%
6 Month
+37.9%
+37.9%
1 Year
+237.1%
+237.1%

More News

Read More
News headline image
Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in Upcoming Investor Conferences
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health (GH) Q2 Earnings Report Preview: What To Look For
Via StockStory
Guardant Health Inc. (NASDAQ:GH) Shines as a Top Minervini Trend Template and High Growth Momentum Pick ↗
Via Chartmill
News headline image
Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
From Guardant Health, Inc.
Via Business Wire
News headline image
UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Mid-Cap Stocks We’re Skeptical Of
Via StockStory
News headline image
Why Are Guardant Health (GH) Shares Soaring Today
Via StockStory
Topics Artificial Intelligence
News headline image
Why Are Guardant Health (GH) Shares Soaring Today
Via StockStory
News headline image
3 Russell 2000 Stocks We Approach with Caution
Via StockStory
Topics Energy
News headline image
Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®
From Guardant Health, Inc.
Via Business Wire
News headline image
Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗
Via The Motley Fool
News headline image
1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds
Via StockStory
Topics Bankruptcy
News headline image
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
Via StockStory
News headline image
3 Unprofitable Stocks Walking a Fine Line
Via StockStory
Topics Electric Vehicles
News headline image
3 Reasons GH is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Bankruptcy Stocks Supply Chain
News headline image
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders
Via StockStory
News headline image
Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting
From Guardant Health, Inc.
Via Business Wire
News headline image
American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Growth Stocks We’re Skeptical Of
Via StockStory
News headline image
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Guardant Health, Inc. - Common Stock publicly traded?
Yes, Guardant Health, Inc. - Common Stock is publicly traded.
What exchange does Guardant Health, Inc. - Common Stock trade on?
Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Guardant Health, Inc. - Common Stock?
The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
What is the current price of Guardant Health, Inc. - Common Stock?
The current price of Guardant Health, Inc. - Common Stock is 152.35
When was Guardant Health, Inc. - Common Stock last traded?
The last trade of Guardant Health, Inc. - Common Stock was at 07/30/26 04:00 PM ET
What is the market capitalization of Guardant Health, Inc. - Common Stock?
The market capitalization of Guardant Health, Inc. - Common Stock is 15.43B
How many shares of Guardant Health, Inc. - Common Stock are outstanding?
Guardant Health, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.